Latest biopharmaceutical Stories
- Treatment with RG-012 Protects Kidney Function and Demonstrates Additive Therapeutic Effect with Emerging Standard of Care in Preclinical Model of Alport Syndrome - LA JOLLA, Calif.,
U.S. Patent No. 8,871,493 "Transformation system in the field of filamentous fungal hosts" JUPITER, Fla., Nov. 12, 2014 /PRNewswire/ -- Dyadic International, Inc.
All amounts are in US dollars QUEBEC CITY, Nov. 4, 2014 /PRNewswire/ - Aeterna Zentaris Inc.
DALLAS and NEW YORK, Nov. 4, 2014 /PRNewswire/ -- PlasmaTech Biopharmaceuticals, Inc.
JUPITER, Fla., Nov. 3, 2014 /PRNewswire/ -- Dyadic International, Inc.
DALLAS, November 3, 2014 /PRNewswire/ -- According to the new market research report The "Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal
MONROVIA, Calif., Nov. 3, 2014 /PRNewswire/ -- Xencor, Inc.
Conference Call and Webcast to Follow THE WOODLANDS, Texas, Nov.
JUPITER, Fla., Oct. 30, 2014 /PRNewswire/ -- Dyadic International, Inc.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.